Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
Clinical trial NCT07052383 · RECRUITING
Trial details
- NCT number
- NCT07052383
- Sponsor
- Tcelltech Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-06
- Primary completion
- 2027-10-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.